NEW YORK - Questioning whether Novartis Pharmaceuticals Corp. is "getting the message," the New York U.S. attorney on April 26 filed his second False Claims Act complaint against the drug manufacturer in three days, this time alleging that the company paid kickbacks in the form of lavish "educational programs" to induce doctors to prescribe three of the company's drugs (United States of America, ex rel. Oswald Bilotta v. Novartis Pharmaceuticals Corporation, United States...(read more)![]()
↧